8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule

RxCUI
1600916
RxNorm name
8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule
Display name
8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule
Full name
8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Carbidopa and LevodopaCARBIDOPA AND LEVODOPAREMEDYREPACK INC.b29e58f0-67b1-4036-a4a8-4915a8c13cdf2026-04-24Warnings, Adverse reactionsExact identifier
rxcui: 1600916
RYTARYCARBIDOPA AND LEVODOPAAmneal Pharmaceuticals LLC6c1f7cd4-de56-45c1-a734-5e77b4aeb6f72026-03-26Warnings, Adverse reactionsExact identifier
rxcui: 1600916
Carbidopa and LevodopaCARBIDOPA AND LEVODOPAZydus Pharmaceuticals USA Inc.74e7f96b-de31-4e3c-b32d-11421b291d4e2025-11-14Warnings, Adverse reactionsExact identifier
rxcui: 1600916

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7carbidopa 61.25 MG / levodopa 245 MG 8HR Extended Release Oral Capsule [PSN] · 8 HR carbidopa 61.25 MG / levodopa 245 MG Extended Release Oral Capsule [SCD] · 8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule [SY] · carbidopa 61.25 MG / levodopa 245 MG 8 HR Extended Release Oral Capsule [SY]426These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 197520260326
74e7f96b-de31-4e3c-b32d-11421b291d4ecarbidopa 61.25 MG / levodopa 245 MG 8HR Extended Release Oral Capsule [PSN] · 8 HR carbidopa 61.25 MG / levodopa 245 MG Extended Release Oral Capsule [SCD] · 8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule [SY] · carbidopa 61.25 MG / levodopa 245 MG 8 HR Extended Release Oral Capsule [SY]42These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 197520251114
b29e58f0-67b1-4036-a4a8-4915a8c13cdfcarbidopa 61.25 MG / levodopa 245 MG 8HR Extended Release Oral Capsule [PSN] · 8 HR carbidopa 61.25 MG / levodopa 245 MG Extended Release Oral Capsule [SCD] · 8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule [SY] · carbidopa 61.25 MG / levodopa 245 MG 8 HR Extended Release Oral Capsule [SY]41These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 197520260424